As of 4:00pm ET
| -0.05 / -2.24%|
The 6 analysts offering 12-month price forecasts for Ovid Therapeutics Inc have a median target of 11.50, with a high estimate of 20.00 and a low estimate of 7.00. The median estimate represents a +427.52% increase from the last price of 2.18.
The current consensus among 8 polled investment analysts is to Buy stock in Ovid Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.